Evidence map›Paper›PMID 24886964›Full record

ArticleApplied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine2014

Performance of a ⁶²Zn/⁶²Cu microgenerator in kit-based synthesis and delivery of [⁶²Cu]Cu-ETS for PET perfusion imaging.

Yen Ng, Jeffrey L Lacy, James W Fletcher, Mark A Green

Open access · bronzeAbstract read
In one paragraph

Article in Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. A nuclear chocolate box: the periodic table of nuclear medicine.Dalton transactions (Cambridge, England : 2003) · 2015
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Yen NgIndiana University School of Medicine, Indianapolis, IN, USA.
Jeffrey L LacyProportional Technologies, Inc. (PTI), Houston, TX, USA.
James W FletcherIndiana University School of Medicine, Indianapolis, IN, USA.
Mark A GreenIndiana University School of Medicine, Indianapolis, IN, USA. Electronic address: magreen@iu.edu.
Indiana University School of MedicineIndiana University – Purdue University Indianapolis · USProportional Technologies · US

Funding

Whole-Body PET/CT Assessment of Tumor Perfusion Using Generator-Produced 62CuR01CA140299 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI FLETCHER, JAMES W, GREEN, MARK A · 2009 to 2012
$1.8M
NCI NIH HHS R01 CA140299NCI NIH HHS R01-CA140299
6 · The paper itself

Abstract

The performance of a commercially produced (62)Zn/(62)Cu microgenerator system, and an associated kit-based radiopharmaceutical synthesis method, was evaluated for clinical site production of [(62)Cu]Cu-ETS (ethylglyoxal bis(thiosemicarbazonato)copper(II)), an investigational agent for PET perfusion imaging. Using 37 generators, containing 1.84±0.23 GBq (62)Zn at 9:00 AM on the day of clinical use, a total of 45 patient doses of [(62)Cu]Cu-ETS (672±172 MBq) were delivered without difficulty. (62)Cu elution yields were high (approximately 90%), accompanied by extremely low (62)Zn breakthrough (<0.001%). Radiopharmaceutical preparation, from the start-of-elution to time-of-injection, consumed less than five minutes. The (62)Zn/(62)Cu microgenerator was a dependable source of short-lived positron-emitting (62)Cu, and the kit-based synthesis proved to be rapid, robust, and highly reliable for "on-demand" delivery of [(62)Cu]Cu-ETS for PET perfusion imaging.

Indexed as

Copper RadioisotopesHead and Neck NeoplasmsHumansKidney NeoplasmsOrganometallic CompoundsPerfusion ImagingPositron-Emission TomographyRadionuclide GeneratorsRadiopharmaceuticalsThiosemicarbazonesZinc RadioisotopesCopper Radioisotopesethylglyoxal bis(thiosemicarbazonato)copper(II)Organometallic CompoundsRadiopharmaceuticalsThiosemicarbazonesZinc Radioisotopes[(62)Cu]Cu–ETS (copper(II) ethylglyoxal bis(thiosemicarbazone))(62)Zn/(62)Cu generatorPET radiopharmaceuticalsTumor perfusion

Identifiers

PMID24886964
PMCPMC4209963
OpenAlexW2014470061

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.